161455-85-2

Upstream product

• 534-85-0 N-phenyl-1,2-benzenediamine 
• 100-07-2 4-methoxy-benzoyl chloride 
• 161455-84-1 4-methoxy-N-(2-(phenylamino)phenyl)benzamide 

Downstream Products

• 161455-86-3 1-(4-Methoxy-benzyl)-5-phenyl-3-(phenyl-hydrazono)-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione 
• 173908-74-2 [2-({2-[2,4-Dioxo-5-phenyl-3-(3-phenyl-ureido)-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl]-acetyl}-phenyl-amino)-ethyl]-carbamic acid benzyl ester 
• 173908-72-0 ({2-[2,4-Dioxo-5-phenyl-3-(3-phenyl-ureido)-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl]-acetyl}-phenyl-amino)-acetic acid ethyl ester 
• 173908-91-3 1-(2,4-dioxo-1-phenyl-2,3,4,5-tetrahydro-1H-benzo<1,4>diazepin-3-yl)-3-phenylurea 
• 173908-90-2 3-amino-1-(4-methoxybenzyl)-5-phenyl-1,5-dihydrobenzo<1,4>diazepine-2,4-dione 
• 153930-38-2 3-amino-1-phenyl-1,5-dihydrobenzo<1,4>diazepine-2,4-dione 

Relevant academic research and scientific papers

Use of 1,5-benzo?b!1,4-diazepines to control gastric emptying

A method of controlling gastric emptying in patients having an early non-insulin-dependent diabetic condition and exhibiting rapid gastric emptying comprising the administration of an effective gastric emptying controlling amount of a compound of Formula

Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger"

Directed screening of compounds selected from the Glaxo registry file for contractile activity on the isolated guinea pig gallbladder (GPGB) identified a series of 1,5-benzodiazepines with peripheral cholecystokinin (CCK) receptor agonist activity. Agonis